Friday, June 9th 2017 - Today, leading global business development database Biotechgate presents its 2017 trend report for the Dutch life sciences market. The annual trend report for the Dutch life sciences market shows that the country remains an important centre of the industry.
There were 14 major financing rounds in the biotech sector in 2016 for the total amount of 71 million USD. However, the number of newly founded companies was much lower in 2016 than in the previous years. According to our data, there are almost 500 biotech and around 120 medtech companies in Netherlands at the moment. For the first time, we included the health sector in our analysis as it grew significantly in recent years.
Biotechgate is a global business development database containing over 40,000 company profiles and providing the user with information on available licensing products, financing rounds, key management, technology platforms and more.
Whether you are looking to partner with a Dutch company or looking for a specific service, you’ll find the most complete overview of the Dutch life sciences sector at www.dutchbiotech.com